Results 91 to 100 of about 64,045 (290)

Crystallization after intravitreal ganciclovir injection

open access: yes, 2010
Pitipol Choopong, Nattaporn Tesavibul, Nattawut RodanantDepartment of Ophthalmology, Siriraj Hospital, Mahidol University, Bangkok, ThailandPurpose: To report crystal formation as a complication of intravitreal ganciclovir injection.Patients and methods:
Nattawut Rodanant   +2 more
core  

Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab

open access: yes, 2011
Christina Antonopoulos1, Maxwell Stem2, Grant M Comer21Department of Ophthalmology, Boston University, Boston, MA, USA; 2WK Kellogg Eye Center, Department of Ophthalmology, University of Michigan, Ann Arbor, MI, USAPurpose: Previous reports have ...
Antonopoulos C   +5 more
core   +1 more source

Real‐world incidence and clinical characteristics of intraocular inflammation following intravitreal faricimab therapy: A safety study

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To estimate the real‐world incidence of intraocular inflammation (IOI) following intravitreal faricimab injections at a large, highly specialized tertiary centre. Methods Single‐centre, retrospective cohort study with chart review using an electronic injection database and electronic medical records from November 2023 to August 2024 ...
Miklos Schneider   +7 more
wiley   +1 more source

Effects of triamcinolone acetonide on human trabecular meshwork cells in vitro

open access: yesIndian Journal of Ophthalmology, 2014
Aim: To study the effects of triamcinolone acetonide (TA) on cultured human trabecular meshwork (HTM) cells. Materials and Methods: HTM cells were cultured and treated with 125, 250, 500 and 1000 μg/mL concentration of TA for 24 h. The cells were treated
Ashish Sharma   +7 more
doaj   +1 more source

Intravitreal Plungerless Injector Device (IPLID): An Innovative Intravitreal Injector Device [PDF]

open access: yes
Juan B Yepez,1 Felipe A Murati,2 Michele Petitto,3 Igor Kozak,4 J Fernando Arevalo5 1Vitreoretinal Surgery Department, Clinica de Ojos, Maracaibo, Venezuela; 2Sotero del Rio, Hospital, Santiago, Chile; 3Glaucoma Department, Clinica de Ojos, Maracaibo ...
Petitto M   +4 more
core  

Diabetic papillopathy treated with intravitreal ranibizumab

open access: yes, 2017
Mine Yildirim, Deniz Kilic, Mehmet Emin Dursun, Birgul Dursun Department of Ophthalmology, Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey Abstract: In this report, we present a case of diabetic papillopathy that resolved ...
Dursun ME   +7 more
core   +1 more source

Impact of delayed appointments on treatment outcomes in neovascular macular degeneration

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the real‐world visual outcomes of anti‐vascular endothelial growth factor (anti‐VEGF) therapy, the frequency of delayed appointments and the relationship between delays and visual outcomes in patients with neovascular age‐related macular degeneration (nAMD).
Petri Purola   +3 more
wiley   +1 more source

Evaluation of corneal biomechanical properties following penetrating keratoplasty using ocular response analyzer

open access: yesIndian Journal of Ophthalmology, 2014
Purpose: To evaluate corneal biomechanical properties in eyes that has undergone penetrating keratoplasty (PK). Materials and Methods: Retrospective observational study in a tertiary care centre.
Vanathi Murugesan   +4 more
doaj   +1 more source

Dexamethasone intravitreal implant in the treatment of diabetic macular edema

open access: yes, 2015
Pravin U Dugel,1,2 Francesco Bandello,3 Anat Loewenstein4 1Retinal Consultants of Arizona, Phoenix, AZ, 2Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; 3Department of Ophthalmology ...
Dugel PU, Loewenstein A, Bandello F
core  

Visual acuity is reduced with increasing central retinal thickness, but also with higher age and female sex in diabetic macular oedema

open access: yesActa Ophthalmologica, EarlyView.
Abstract Introduction The increasing number of patients with diabetes has increased the incidence of diabetic macular oedema (DME) with the accompanying risk of developing visual loss. The purpose of the present study was to describe the contributions of increased central retinal thickness (CRT) and other risk factors to the reduction in visual acuity ...
Signe Krejberg Jeppesen, Toke Bek
wiley   +1 more source

Home - About - Disclaimer - Privacy